Roundup: Fred launches third-party apps market and extra briefs
Fred launches third-party apps market for pharmacies
Australian pharmacy IT options supplier Fred IT Group has launched a web-based market of third-party functions for pharmacies.
Known as Fred Market, the web-based hub has options which have been accepted and examined to be used with Fred’s software program, together with apps and integrations for robots, eCommerce, enterprise intelligence, medical companies, drug info and drugs administration, loyalty and cost.
Third-party options come from Fred’s trusted vendor companions, particularly BD, Dataology, GuildLink, LifeSmart, MIMs, Modeus, Storbie, StrongRoom, Tyro, and Willach Pharmacy Options.
{The marketplace} will proceed to convey on new software program companions and accepted functions because it expands.
College of South Australia researchers develop fibre sensors to remotely monitor sufferers
Scientists from the College of South Australia have developed tiny optical fibre sensors to remotely observe the positions of sufferers coping with painful stress sores in their beds.
“Annually, 1000’s of older Australians in hospitals and nursing houses expertise stress accidents, or ulcers, which take a very long time to heal and will be deadly. On the very least, these accidents could cause extreme ache, disrupt sleep, have an effect on their temper, in addition to their rehabilitation, mobility and high quality of life,” stated Dr Stephen Warren-Smith, the lead researcher behind the brand new know-how.
The fibre sensors are connected to the higher floor of a mattress to watch motion and file coronary heart and respiratory charges.
By choosing up their respiratory, the unobtrusive sensors can detect when a affected person turns over, leaves a mattress, or stays immobile. Nurses will be prompted if a affected person has not moved for hours so they might alter their place.
Present strategies to watch sufferers coping with stress sores use weight-based sensors, which can not predict when a affected person leaves the mattress till their ft contact the ground. Digicam-based applied sciences are additionally getting used, though privateness is a significant concern.
EpiAxis Therapeutics, Peptilogics companion for AI drug discovery
Australian drug developer EpiAxis Therapeutics and Peptilogics, a US-based biotechnology firm, will harness AI in drug discovery to inhibit epigenetic oncology targets.
Their mission will make use of Peptilogics’ AI platform Nautilus, along with EpiAxis’s experience in epigenetics, to advance drug discovery for cancers that escape present therapies by epigenetic change, together with metastatic breast most cancers.
“We’ll deal with lead optimisation utilizing Peptilogics’ Nautilus platform, which mixes proprietary deep generative fashions, predictive fashions, and biophysical simulation to design multiparameter-optimised peptides with [the] potential to deal with traditionally difficult and novel drug targets,” stated Peptilogics CTO Nicholas Nystrom.
This partnership follows EpiAxis’s lately concluded medical trial which for the primary time has used an epigenetic inhibitor alongside chemotherapy to deal with metastatic most cancers.